Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Recruiting

Phase 2

Tranexamic AcidEvaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Sponsor:

University of Manitoba

Code:

NCT06599762

Conditions

Myelodysplastic Syndromes

Acute Myeloid Leukemia

Myelodysplastic/Myeloproliferative Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tranexamic acid

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-14. This information was provided to ClinicalTrials.gov by University of Manitoba on 2026-04-22.